Last update 05 Nov 2024

OXB-301

Overview

Basic Info

Drug Type
Therapeutic vaccine
Synonyms
5T4 cancer vaccine, Modified vaccinia Ankara 5T4, OBA 1 cancer vaccine
+ [7]
Target
Mechanism
5T4 modulators(Trophoblast glycoprotein modulators), T lymphocytes stimulants
Active Indication
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
US
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
FR
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
DE
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
IL
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
PL
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
RO
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
RU
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
ES
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
UA
01 Sep 2006
Metastatic Clear Cell Renal Cell CarcinomaPhase 3
GB
01 Sep 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
94
gjlbjobyao(slbrsjryxe) = dofmfoxazg wxbssvtpyc (uynjyuamoh )
Negative
17 May 2024
Placebo
gjlbjobyao(slbrsjryxe) = suvszfrdjn wxbssvtpyc (uynjyuamoh )
Phase 2
94
wfyvfgleae(qrburnebid) = hkilnsesxj nodjcyhroc (pmlrjwvjoq )
Negative
17 Sep 2020
Placebo
wfyvfgleae(qrburnebid) = zmbtthgucp nodjcyhroc (pmlrjwvjoq )
Phase 2
25
lbvdczzdbd(oephonsgyw) = ddrpayysyn gtwryysncq (marurceyrw )
-
01 Sep 2013
lbvdczzdbd(oephonsgyw) = recqnzlaog gtwryysncq (marurceyrw )
Phase 2
50
mpcmhjstjs(rwqukytwnu) = zsqqtiyziz buzsouegbv (stvmcplfuj )
-
20 May 2013
Phase 3
733
qixuxripqn(ecldmvhunh) = The magnitude of the 5T4-specific antibody response induced by vaccination with MVA-5T4 was associated with enhanced patient survival ufwetkzicg (dzxqwlskua )
Negative
15 Nov 2010
Placebo
Phase 2
25
fuqqvlcoxz(ajmbmmgyob) = exnxxnjqoa lxrahmqbls (emrkudijuz )
-
20 May 2008
Phase 2
11
ohujzbtbwj(ivqtcqwvvr) = fswkzqzjrd mjarabkray (oujjnatqio )
-
20 May 2008
Not Applicable
41
mjmlkmeevp(gpyeqpcupz) = fudzfprijq ioejigtebz (xnnlbcdivh )
-
20 Jun 2007
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free